{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:25:15Z","timestamp":1787837115143,"version":"build-2784847793"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"abstract":"<jats:sec>\n                    <jats:title>AIMS:<\/jats:title>\n                    <jats:p>The purpose of this study is to present our center's experience in managing patients with pulmonary arterial hypertension (PAH). The main objective is to describe patients' management profile and treatment outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This study presents the results from a single pulmonary hypertension (PH) specialized center in Saudi Arabia. Both incidence and prevalence cases are included. We have previously reported the clinical and physiological characteristics at the time of diagnosis for this cohort of patients. In this study, we describe the clinical management and the outcome of therapy in the same cohort, who were prospectively followed for a mean of 22 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      A total of 107 patients were identified as having PAH. At the time of enrollment, 56.1% of patients were in modified New York Heart Association functional class (NYHA FC) III and 16.8% were in IV. Phosphdiesterase-5 inhibitor was the most commonly used target therapy (82.2%) followed by endothelin receptors antagonist (74.4%). Only five patients (4.7%) were candidate to use calcium channel blockers. Seventy-nine patients (73.8 %) received a combination nonparenteral target therapy. Thirty-one patients (28.9%) died during the follow-up period. Modified NYHA FC III and IV patients, portopulmonary hypertension, heritable PAH, and PAH associated with connective tissue diseases had the highest mortality rate (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Our patients are detected at advanced stage of the disease, and thus the mortality is still unacceptably high. Advanced functional class at presentation and certain disease subgroups are associated with increased mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/1817-1737.160842","type":"journal-article","created":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T04:19:24Z","timestamp":1458101964000},"page":"204-211","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Saudi experience in the management of pulmonary arterial hypertension; the outcome of PAH therapy with the exclusion of chronic parenteral prostacyclin"],"prefix":"10.4103","volume":"10","author":[{"given":"Majdy","family":"Idrees","sequence":"first","affiliation":[{"name":"Pulmonary Medicine Division, Prince Sultan Medical Military City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Alnajashi","sequence":"additional","affiliation":[{"name":"Section of Congenital Heart Disease, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasim","family":"Abdulhameed","sequence":"additional","affiliation":[{"name":"Section of Congenital Heart Disease, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atika","family":"Khan","sequence":"additional","affiliation":[{"name":"Section of Congenital Heart Disease, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enas","family":"Batubara","sequence":"additional","affiliation":[{"name":"Pulmonary Medicine Division, Prince Sultan Medical Military City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelmajeed","family":"Alotay","sequence":"additional","affiliation":[{"name":"Section of Congenital Heart Disease, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Fayed","sequence":"additional","affiliation":[{"name":"High Institute of Public Health, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh","family":"Aldammas","sequence":"additional","affiliation":[{"name":"Pulmonary Medicine Division, Prince Sultan Medical Military City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moaad","family":"Alseif","sequence":"additional","affiliation":[{"name":"Pulmonary Medicine Division, Prince Sultan Medical Military City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Alawwad","sequence":"additional","affiliation":[{"name":"Pulmonary Medicine Division, Prince Sultan Medical Military City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"Abusabaa","sequence":"additional","affiliation":[{"name":"Pulmonary Medicine Division, Prince Sultan Medical Military City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashael","family":"Almobrad","sequence":"additional","affiliation":[{"name":"Pulmonary Medicine Division, Prince Sultan Medical Military City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Kashour","sequence":"additional","affiliation":[{"name":"Department of Cardiac Science, King Fahd Cardiac Center, King Khalid University Hospital, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Registry Taskforce SAPH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250602","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccm.2006.11.010","article-title":"Pathology of pulmonary hypertension","volume":"28","author":"Tuder","year":"2007","journal-title":"Clin Chest Med"},{"key":"R2-20250602","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"R3-20250602","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: Results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R4-20250602","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1183\/09031936.00101211","article-title":"REHAP investigators. Survival in pulmonary hypertension in Spain: Insights from the Spanish registry","volume":"40","author":"Escribano-Subias","year":"2012","journal-title":"Eur Respir J"},{"key":"R5-20250602","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1378\/chest.06-2913","article-title":"Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension","volume":"132","author":"Jing","year":"2007","journal-title":"Chest"},{"key":"R6-20250602","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1183\/09059180.00008211","article-title":"REVEAL: A contemporary US pulmonary arterial hypertension registry","volume":"21","author":"McGoon","year":"2012","journal-title":"Eur Respir Rev"},{"key":"R7-20250602","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: Insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"R8-20250602","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4103\/1817-1737.140127","article-title":"Pulmonary arterial hypertension in Saudi Arabia: Patients' clinical and physiological characteristics and hemodynamic parameters. A single center experience","volume":"9","author":"Idrees","year":"2014","journal-title":"Ann Thorac Med"},{"key":"R9-20250602","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/1817-1737.109813","article-title":"Pulmonary hypertension: Another light in the dark tunnel. Learning the lesson from cancer","volume":"8","author":"Idrees","year":"2013","journal-title":"Ann Thorac Med"},{"key":"R10-20250602","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/eurheartj\/ehp022","article-title":"A meta-analysis of randomized controlled trials in pulmonary arterial hypertension","volume":"30","author":"Galie","year":"2009","journal-title":"Eur Heart J"},{"key":"R11-20250602","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/01.CIR.0000029100.82385.58","article-title":"Survival in primary pulmonary hypertension: The impact of epoprostenol therapy","volume":"106","author":"McLaughlin","year":"2002","journal-title":"Circulation"},{"key":"R12-20250602","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: Prognostic factors and survival","volume":"40","author":"Sitbon","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R13-20250602","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.CIR.102.8.865","article-title":"Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension","volume":"102","author":"Nagaya","year":"2000","journal-title":"Circulation"},{"key":"R14-20250602","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/ajrccm.161.2.9906015","article-title":"Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing","volume":"161","author":"Miyamoto","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-20250602","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/01.CIR.0000022687.18568.2A","article-title":"Assessment of survival in patients with primary pulmonary hypertension: Importance of cardiopulmonary exercise testing","volume":"106","author":"Wensel","year":"2002","journal-title":"Circulation"},{"key":"R16-20250602","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1183\/09031936.04.00122204","article-title":"End-points in pulmonary arterial hypertension: The way forward","volume":"23","author":"Peacock","year":"2004","journal-title":"Eur Respir J"},{"key":"R17-20250602","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1183\/09031936.02.05542002","article-title":"The new clinical trials on pharmacological treatment in pulmonary arterial hypertension","volume":"20","author":"Galie","year":"2002","journal-title":"Eur Respir J"},{"key":"R18-20250602","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/01.CIR.95.6.1479","article-title":"Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group","volume":"95","author":"Hinderliter","year":"1997","journal-title":"Circulation"},{"key":"R19-20250602","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0735-1097(02)01744-8","article-title":"Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension","volume":"39","author":"Raymond","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R20-20250602","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1183\/09059180.00006711","article-title":"Prognostic factors in pulmonary arterial hypertension: Assessing the course of the disease","volume":"20","author":"Howard","year":"2011","journal-title":"Eur Respir Rev"},{"key":"R21-20250602","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0002-9149(98)00140-4","article-title":"Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension","volume":"81","author":"Yeo","year":"1998","journal-title":"Am J Cardiol"},{"key":"R22-20250602","first-page":"152","article-title":"Retrospective study of pulmonary hypertensive patients: Is right ventricular myocardial performance index a vital prognostic factor?","volume":"48","author":"Grapsa","year":"2007","journal-title":"Hellenic J Cardiol"},{"key":"R23-20250602","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijcard.2008.11.051","article-title":"Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension","volume":"140","author":"Ghio","year":"2010","journal-title":"Int J Cardiol"},{"key":"R24-20250602","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1164\/rccm.200604-547OC","article-title":"Tricuspid annular displacement predicts survival in pulmonary hypertension","volume":"174","author":"Forfia","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R25-20250602","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1183\/09031936.00092311","article-title":"The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension","volume":"39","author":"Nickel","year":"2012","journal-title":"Eur Respir J"},{"key":"R26-20250602","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.1016\/j.jacc.2004.02.032","article-title":"Diagnosis and differential assessment of pulmonary arterial hypertension","volume":"43","author":"Barst","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R27-20250602","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1183\/09031936.05.00054804","article-title":"Survival with first-line bosentan in patients with primary pulmonary hypertension","volume":"25","author":"McLaughlin","year":"2005","journal-title":"Eur Respir J"},{"key":"R28-20250602","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/2045-8932.101655","article-title":"The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension","volume":"2","author":"Zeng","year":"2012","journal-title":"Pulm Circ"},{"key":"R29-20250602","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1164\/rccm.201203-0383OC","article-title":"Changing demographics, epidemiology and survival of incident pulmonary arterial hypertension: Results from the pulmonary hypertension registry of the united Kingdom and Ireland","volume":"186","author":"Ling","year":"2012","journal-title":"Am J respire Crit care Med"},{"key":"R30-20250602","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.4103\/1817-1737.134006","article-title":"Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: 2014 updates","volume":"9","author":"Idrees","year":"2014","journal-title":"Ann Thorac Med"}],"container-title":["Annals of Thoracic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01284540-201510030-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:16:37Z","timestamp":1787836597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01284540-201510030-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.4103\/1817-1737.160842","relation":{},"ISSN":["1817-1737","1998-3557"],"issn-type":[{"value":"1817-1737","type":"print"},{"value":"1998-3557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"2015-02-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-04-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}